Titleist Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Titleist Asset Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-30,961	Closed	-$304K	–	305
2024 Q4	$304K	Sell	30,961 -22,070	-42%	-$189K	0.03%	249
2024 Q3	$432K	Sell	53,031 -3,690	-7%	-$37K	0.06%	187
2024 Q2	$758K	Sell	56,721 -8,269	-13%	-$247K	0.11%	128
2024 Q1	$3.02M	Sell	64,990 -614	-0.9%	-$31.8K	0.53%	52
2023 Q4	$4.43M	Buy	65,604 +1,266	+2%	+$77.5K	0.82%	28
2023 Q3	$4.66M	Buy	64,338 +1,031	+2%	+$82.4K	0.96%	24
2023 Q2	$4.71M	Buy	63,307 +917	+1%	+$54.3K	0.93%	26
2023 Q1	$3.32M	Buy	+62,390	New	+$3.95M	0.7%	32

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Titleist Asset Management's DNA Position: Q1 2025 in Review

Titleist Asset Management sold out of Ginkgo Bioworks (DNA) in Q1 2025, closing a stake of 30,961 shares — an estimated $304K sold.

Titleist Asset Management first reported a position in DNA in Q1 2023 and held it in 8 quarters. The position peaked at $4.71M in Q2 2023. 167 funds tracked by Wall St. Rank hold DNA as of Q1 2025.

Titleist Asset Management reported no remaining Ginkgo Bioworks position as of Q1 2025 after selling out during the quarter.
Titleist Asset Management sold 30,961 Ginkgo Bioworks shares in Q1 2025, an estimated $304K.
Titleist Asset Management first reported a position in Ginkgo Bioworks in Q1 2023 and held it in 8 quarters.
Titleist Asset Management's Ginkgo Bioworks position peaked at $4.71M in Q2 2023.
167 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2025.

Based on Titleist Asset Management's 13F filing for Q1 2025, filed 15 May 2025.